Universal Vision Biotechnology Co., Ltd.(TW:3218)
NT$126.000.00 (0.00%)
TW:3218
Universal Vision Biotechnology Co., Ltd. financials statements
NT$126.00
At close:0.00 (0.00%)
Universal Vision Biotechnology Co., Ltd. (3218) Income Statement
Universal Vision Biotechnology Co., Ltd. Income Statement
Last quarter (Q2 2026), Universal Vision Biotechnology Co., Ltd.'s total revenue was NT$1.13B, an increase of 10.12% from the same quarter last year. In Q2, Universal Vision Biotechnology Co., Ltd.'s net income was NT$226.46M. See Universal Vision Biotechnology Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 4.20B | NT$ 4.23B | NT$ 4.08B | NT$ 3.49B | NT$ 2.63B | |
| NT$ 2.48B | NT$ 2.53B | NT$ 2.45B | NT$ 2.14B | NT$ 1.64B | |
| NT$ 1.10B | NT$ 1.13B | NT$ 1.14B | NT$ 1.05B | NT$ 867.59M | |
| Depreciation and Amortization | NT$ 543.79M | NT$ 521.49M | NT$ 446.15M | NT$ 372.25M | NT$ 319.52M |
| NT$ 1.92B | NT$ 1.86B | NT$ 1.78B | NT$ 1.48B | NT$ 1.10B | |
| NT$ 1.38B | NT$ 1.40B | NT$ 1.31B | NT$ 1.11B | NT$ 776.59M | |
| NT$ -34.65M | NT$ -82.31M | NT$ 6.73M | NT$ -21.21M | NT$ -5.75M | |
| NT$ 1.35B | NT$ 1.32B | NT$ 1.32B | NT$ 1.09B | NT$ 763.11M | |
| NT$ 1.04B | NT$ 1.06B | NT$ 1.05B | NT$ 850.53M | NT$ 595.43M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 12.31 | NT$ 12.59 | NT$ 12.34 | NT$ 10.04 | NT$ 7.03 |
| Diluted EPS | NT$ 12.31 | NT$ 12.54 | NT$ 12.31 | NT$ 10.02 | NT$ 7.02 |
| Weighted Average Shares Outstanding | 85.67M | 84.72M | 84.69M | 84.72M | 84.72M |
| Weighted Average Shares Outstanding (Diluted) | 85.67M | 84.96M | 84.89M | 84.86M | 84.83M |
Currency in TWD

